Cargando…

Altered PPP2R2A and Cyclin D1 expression defines a subgroup of aggressive luminal-like breast cancer

BACKGROUND: PPP2R2A deletions were recently linked to a subgroup of luminal breast carcinoma (BC) that exhibits poor survival. This subgroup also exhibited amplification of a chromosome region containing the Cyclin D1 coding gene, CCND1. Therefore, we aimed to investigate whether a combination of PP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beca, Francisco, Pereira, Miguel, Cameselle-Teijeiro, Jorge F, Martins, Diana, Schmitt, Fernando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409761/ https://www.ncbi.nlm.nih.gov/pubmed/25879784 http://dx.doi.org/10.1186/s12885-015-1266-1

Ejemplares similares

Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer
por: Costa, Sandra, et al.
Publicado: (2008)

Significance of Targeting VEGFR-2 and Cyclin D1 in Luminal-A Breast Cancer
por: N. Abdalla, Ashraf, et al.
Publicado: (2020)

Nottingham Prognostic Index in Triple-Negative Breast Cancer: a reliable prognostic tool?
por: Albergaria, André, et al.
Publicado: (2011)

PPP/INS Tight Integration with BDS−3 PPP−B2b Service in the Urban Environment
por: Lai, Luguang, et al.
Publicado: (2023)

Mutations in the PP2A regulatory subunit B family genes PPP2R5B, PPP2R5C and PPP2R5D cause human overgrowth
por: Loveday, Chey, et al.
Publicado: (2015)

Aggressiveness of the tall cell variant of papillary thyroid carcinoma is independent of the tumor size and patient age
por: Villar-Taibo, Rocío, et al.
Publicado: (2017)

Corrigendum: Mutations in the PP2A regulatory subunit B family genes PPP2R5B, PPP2R5C and PPP2R5D cause human overgrowth
por: Loveday, Chey, et al.
Publicado: (2019)

Analysing the Zenith Tropospheric Delay Estimates in On-line Precise Point Positioning (PPP) Services and PPP Software Packages
por: Mendez Astudillo, Jorge, et al.
Publicado: (2018)

Cribriform-morular variant of thyroid carcinoma
por: Cameselle-Teijeiro, J.M., et al.
Publicado: (2019)

High phosphorylated cyclin-dependent kinase 2 expression indicates poor prognosis of luminal androgen receptor triple-negative breast cancer: pCDK2 in luminal androgen receptor TNBC
por: Jin, Zining, et al.
Publicado: (2022)

Classification of Subgroups with Immune Characteristics Based on DNA Methylation in Luminal Breast Cancer
por: Zhang, Mengyan, et al.
Publicado: (2022)

Quantum-based modeling implies that bidentate Arg(89)-substrate binding enhances serine/threonine protein phosphatase-2A(PPP2R5D/PPP2R1A/PPP2CA)-mediated dephosphorylation
por: Salter, E. Alan, et al.
Publicado: (2023)

Loss of NF2 defines a genetic subgroup of non‐FOS‐rearranged osteoblastoma
por: Saba, Karim H, et al.
Publicado: (2020)

Comprehensive functional analysis of the tousled-like kinase 2 frequently amplified in aggressive luminal breast cancers
por: Kim, Jin-Ah, et al.
Publicado: (2016)

Extracellular Vesicles Induce an Aggressive Phenotype in Luminal Breast Cancer Cells Via PKM2 Phosphorylation
por: Kang, Seo Young, et al.
Publicado: (2021)

PAX2 is activated by estradiol in breast cancer cells of the luminal subgroup selectively, to confer a low invasive phenotype
por: Beauchemin, David, et al.
Publicado: (2011)

Improving GNSS PPP Convergence: The Case of Atmospheric-Constrained, Multi-GNSS PPP-AR
por: Aggrey, John, et al.
Publicado: (2019)

Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups
por: Netanely, Dvir, et al.
Publicado: (2016)

Pitfalls in Challenging Thyroid Tumors: Emphasis on Differential Diagnosis and Ancillary Biomarkers
por: Cameselle-Teijeiro, José Manuel, et al.
Publicado: (2020)

PS: 10$^{13}$ ppp
Publicado: (1975)

PTEN Genetic and Epigenetic Alterations Define Distinct Subgroups in North Indian Breast Cancer Patients
por: Kazim, Zakia, et al.
Publicado: (2019)

Multi-omic alterations of the SWI/SNF complex define a clinical subgroup in lung adenocarcinoma
por: Peinado, Paola, et al.
Publicado: (2022)

RARE-15. Astroblastoma, MN1 altered comprises two molecularly and clinically distinct subgroups defined by the fusion partners BEND2 and CXXC5
por: Schmitt-Hoffner, Felix, et al.
Publicado: (2022)

The varied distribution and impact of RAS codon and other key DNA alterations across the translocation cyclin D subgroups in multiple myeloma
por: Stein, Caleb K., et al.
Publicado: (2017)

Lewis antigen-negative pancreatic cancer: An aggressive subgroup
por: Liu, Chen, et al.
Publicado: (2020)

PPP2R2D suppresses IL-2 production and Treg function
por: Pan, Wenliang, et al.
Publicado: (2020)

Mutational interactions define novel cancer subgroups
por: Kuipers, Jack, et al.
Publicado: (2018)

Erratum to: Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups
por: Netanely, Dvir, et al.
Publicado: (2016)

Identifying prognostic subgroups of luminal-A breast cancer using deep autoencoders and gene expressions
por: Wang, Seunghyun, et al.
Publicado: (2023)

Primary high-grade calcitonin-negative neuroendocrine carcinoma of the thyroid: a very rare cancer
por: Chorny, Joseph A, et al.
Publicado: (2018)

Are cis-spliced fusion proteins pathological in more aggressive luminal breast cancer?
por: Liu, Chia-Chia, et al.
Publicado: (2023)

Expression and distribution of PPP2R5C gene in leukemia
por: Zheng, Haitao, et al.
Publicado: (2011)

PP5 (PPP5C) is a phosphatase of Dvl2
por: Xie, Jianlei, et al.
Publicado: (2018)

Potential Role and Clinical Value of PPP2CA in Hepatocellular Carcinoma
por: Yang, Cheng-Lei, et al.
Publicado: (2021)

A cancer-derived mutation in the PSTAIRE helix of cyclin-dependent kinase 2 alters the stability of cyclin binding
por: Child, Emma S., et al.
Publicado: (2010)

Combined Use of cyclinD1 and Ki67 for Prognosis of Luminal-Like Breast Cancer Patients
por: Hao, Junmei, et al.
Publicado: (2021)

Luminance- and Texture-Defined Information Processing in School-Aged Children with Autism
por: Rivest, Jessica B., et al.
Publicado: (2013)

Characterizing cyclin-dependent kinase 12(CDK12)-altered aggressive prostate cancer: a twelve-case series
por: Iwasawa, Tomohiro, et al.
Publicado: (2022)

Association of type 2 diabetes remission and risk of cardiovascular disease in pre‐defined subgroups
por: Hounkpatin, Hilda, et al.
Publicado: (2021)

On the Problem of Double-Filtering in PPP-RTK
por: Khodabandeh, A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0jbl1sq2mekccho4of7cab4c34